GoHealth’s Q3 2025 results reflect an intentional shift away from volume-driven growth to focus on retention, quality, and strategic flexibility. While revenue dropped significantly year-over-year, the company reinforced its core capabilities to align with changing market dynamics.

GoHealth experienced a challenging second quarter in 2025 with a significant net loss and a decrease in revenue compared to the prior year. The company undertook strategic capital and governance actions, including securing new term loans and amending existing credit agreements, to improve financial flexibility and support future operations, particularly heading into the Medicare annual enrollment period. Despite a decline in submissions and sales per submission, the company aims to strengthen its position in a consolidating industry.

GoHealth, Inc. announced strong first quarter 2025 results with net revenues increasing by 19.1% to $221.0 million and a significant improvement in net loss, which decreased by 54.2% to $9.8 million. Adjusted EBITDA saw a substantial 56.4% increase to $42.1 million, driven by higher submissions and improved operating efficiency.

GoHealth, Inc. reported a strong fourth quarter with net revenues of $389.1 million, a 41% increase compared to the prior year period. Net income was $58.0 million, a substantial improvement compared to the prior year period, and Adjusted EBITDA surged to $117.8 million, a significant 107% increase compared to the prior year period.

GoHealth reported a decrease in net revenues to $118.3 million, but net income improved significantly to $15.4 million. Submissions increased by 2.9% to 166,195. The company completed the acquisition of e-TeleQuote, which added $90.5 million in contract assets and $22.5 million in cash, and recorded a $77.4 million gain on bargain purchase.

GoHealth reported a decrease in net revenues to $105.9 million due to a 6% decrease in total submissions. The company experienced a net loss of $59.3 million, an improvement of $10.9 million compared to the prior year period. Despite the revenue decline, GoHealth is intensifying targeted marketing efforts for the upcoming AEP and focusing on technology advancements in AI and automation.

GoHealth reported a slight increase in net revenues to $185.6 million, with submissions increasing to 216,148. The company experienced a net loss of $21.3 million, an improvement from the prior year, and an Adjusted EBITDA of $26.9 million.

GoHealth reported a strong Q4 2023, with net revenues of $276.7 million, a net loss of $2.3 million, and Adjusted EBITDA of $57.0 million. The company's focus on consumer engagement and strategic initiatives drove significant improvements in profitability and operating cash flow.

GoHealth reported a slight decrease in net revenues for Q3 2023, but saw a significant increase in submissions. The company's net loss and Adjusted EBITDA improved compared to the prior year period. GoHealth is focused on its Encompass solution and operational excellence to drive future growth and profitability.

GoHealth reported a decrease in net revenues but an improvement in net loss and Adjusted EBITDA for Q2 2023. The company is updating its full year 2023 outlook and expects total net revenue of $800 - $850 million and Adjusted EBITDA of $120 - $140 million, both excluding non-Encompass BPO Services.

GoHealth reported a net revenue of $183.2 million and a net loss of $22.5 million for Q1 2023. The company's Adjusted EBITDA was $28.8 million, and it achieved positive cash flow from operations, while the company reiterated its full year 2023 outlook.

GoHealth reported Q4 2022 net revenue of $69.4 million and a net loss of $150.7 million. Full year 2022 positive cash flow from operations of $60.9 million, a $359.9 million improvement compared to the prior year period.

GoHealth's Q3 2022 results showed a 37% decrease in net revenue to $133.1 million and a net loss of $74.7 million, compared to a net loss of $55.5 million in the prior year period. However, the company is focusing on its Encompass solution and reported a 70% higher conversion rate during the Annual Enrollment Period.

GoHealth reported a decrease in net revenue by 19% compared to the prior year period, totaling $158.7 million. The company experienced a net loss of $113.8 million, a significant increase from the previous year's $39.2 million loss. However, Medicare Submitted Policies increased by 9% compared to the prior year period, reaching 177,911.

GoHealth reported a 33% increase in net revenue to $270.6 million for the first quarter of 2022. However, the company experienced a net loss of $37.2 million, compared to a net loss of $7.3 million in the prior year period. The company reaffirmed its full-year 2022 outlook.

GoHealth's fourth quarter 2021 net revenue increased by 1% compared to the prior year period, while the fiscal year 2021 net revenue increased by 21% compared to the prior year period. The fourth quarter net loss was $432.3 million, and the fiscal year net loss was $534.2 million, inclusive of goodwill impairment charges. The company expects full year 2022 net revenue of $900 - $1,100 million.

GoHealth reported a 30% increase in third-quarter revenue to $211.7 million and reaffirmed its full-year 2021 guidance. The company's Medicare—Internal revenue increased 19% to $158.6 million, and Medicare Advantage Approved Submissions increased 100% compared to the prior year period. However, the company experienced a net loss of $55.4 million and a decrease in Adjusted EBITDA due to strategic investments.

GoHealth, Inc. reported a 55% increase in second quarter net revenue to $196.9 million, driven by an 84% increase in Medicare—Internal revenue. The company's investments in the Encompass Platform contributed $17 million in revenue. However, the company reported a net loss of $39.2 million and a decrease in Adjusted EBITDA due to strategic investments in agent capacity and technology.

GoHealth reported a 45% increase in first-quarter revenue to $204.2 million, driven by a 65% increase in the Medicare—Internal segment. The company reaffirmed its full-year 2021 outlook, expecting total net revenue of $1,150 - $1,300 million and Adjusted EBITDA of $345 - $385 million.

GoHealth reported a strong fourth quarter with a 55% increase in net revenue, driven by a 75% revenue growth in the Internal Medicare segment. The company is focused on investing in its platform to drive commissionable revenue growth and sustain long-term growth.

GoHealth reported a strong third quarter with a 52% increase in net revenues to $163.4 million and a 142% increase in adjusted EBITDA to $39.3 million. The company also updated its full year 2020 outlook, expecting net revenues of $850-$890 million and adjusted EBITDA of $270-$290 million.

GoHealth reported a 71% increase in net revenues for the second quarter of 2020, driven by strong Medicare Advantage enrollments. The company's strategic focus on LTV/CAC contributed to industry-leading margins. GoHealth is on track for a record year in fiscal 2020.